
Agilent Technologies A
€ 118.86
-2.4%
Quartalsbericht 2025-Q2
hinzugefügt 29.08.2025
Agilent Technologies Betriebsaufwand 2011-2025 | A
Betriebsaufwand Jährlich Agilent Technologies
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 1.99 B | 1.86 B | 1.76 B | 1.57 B | 1.58 B | 1.52 B | 2.76 B | 2.58 B | 2.48 B | 2.46 B |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.76 B | 1.52 B | 2.06 B |
Betriebsaufwand anderer Aktien in der Diagnostik & Forschung
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M | ||
|
Burning Rock Biotech Limited
BNR
|
726 M | $ 16.36 | -4.05 % | $ 176 M | ||
|
Brainsway Ltd.
BWAY
|
29.2 M | $ 17.05 | -2.15 % | $ 99.4 M | ||
|
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
41.3 M | $ 1.63 | -2.11 % | $ 2.07 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M | ||
|
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | ||
|
IQVIA Holdings
IQV
|
2.94 B | $ 221.54 | -1.96 % | $ 40.2 B | ||
|
Castle Biosciences
CSTL
|
59.5 M | $ 38.85 | 2.32 % | $ 1.08 B | ||
|
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | ||
|
Danaher Corporation
DHR
|
6.71 B | $ 227.08 | -2.28 % | $ 166 B | ||
|
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | ||
|
DarioHealth Corp.
DRIO
|
62.2 M | $ 11.92 | -6.58 % | $ 338 M | ||
|
DexCom
DXCM
|
1.69 B | $ 66.91 | -2.94 % | $ 25.8 B | ||
|
CareDx, Inc
CDNA
|
484 M | $ 20.44 | 3.23 % | $ 1.1 B | ||
|
Celcuity
CELC
|
113 M | $ 105.26 | 4.46 % | $ 4.15 B | ||
|
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
9.98 M | $ 3.59 | -25.21 % | $ 115 K | ||
|
Exact Sciences Corporation
EXAS
|
2.98 B | $ 101.58 | 0.21 % | $ 18.8 B | ||
|
Co-Diagnostics
CODX
|
45.3 M | $ 0.34 | -2.96 % | $ 9.98 M | ||
|
Fulgent Genetics
FLGT
|
181 M | $ 27.13 | 0.26 % | $ 820 M | ||
|
Guardant Health
GH
|
226 M | $ 102.09 | 0.7 % | $ 12.5 B | ||
|
Aspira Women's Health
AWH
|
37.1 M | - | -6.19 % | $ 10.5 M | ||
|
Koninklijke Philips N.V.
PHG
|
7.12 B | $ 26.6 | -1.52 % | $ 20 B | ||
|
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
3.69 B | $ 134.29 | -1.58 % | $ 21.4 B | ||
|
Charles River Laboratories International
CRL
|
607 M | $ 192.57 | -0.96 % | $ 9.89 B | ||
|
Quidel Corporation
QDEL
|
285 M | $ 28.79 | -2.93 % | $ 1.21 B | ||
|
Quotient Limited
QTNT
|
106 M | - | -11.32 % | $ 1.1 M | ||
|
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 182.21 | 0.35 % | $ 20.2 B | ||
|
Biodesix
BDSX
|
106 M | $ 7.94 | -1.0 % | $ 1.03 B | ||
|
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 263.51 | -0.46 % | $ 22.1 B | ||
|
ICON Public Limited Company
ICLR
|
408 M | $ 186.28 | -1.92 % | $ 15.4 B | ||
|
IDEXX Laboratories
IDXX
|
1.25 B | $ 701.07 | -0.91 % | $ 57.8 B | ||
|
Lantheus Holdings
LNTH
|
123 M | $ 66.11 | 4.76 % | $ 4.57 B | ||
|
Biomerica
BMRA
|
5.64 M | $ 2.55 | -1.07 % | $ 5.86 M | ||
|
Bioventus
BVS
|
217 M | $ 7.59 | 2.29 % | $ 475 M | ||
|
Check-Cap Ltd.
CHEK
|
14.1 M | - | - | $ 9.42 M | ||
|
Motus GI Holdings
MOTS
|
18.6 M | - | -34.28 % | $ 263 K | ||
|
Mettler-Toledo International
MTD
|
1.01 B | $ 1 395.23 | -1.85 % | $ 29.6 B | ||
|
Myriad Genetics
MYGN
|
709 M | $ 7.26 | -0.62 % | $ 658 M | ||
|
ENDRA Life Sciences
NDRA
|
10.8 M | $ 5.47 | -7.6 % | $ 2.94 M |